Jung Joo Moon - New York NY, US Sung Woo Moon - Seoul, KR
International Classification:
C12Q 1/70
Abstract:
The present invention relates to a diagnostic assay for the virus causing severe acute respiratory syndrome Sars-CoV 2 (COVID-19, COVID-19; COVID-19-CoV-2) in humans (“COVID-19 virus”). In particular, the invention relates to a real-time quantitative PCR assay for the detection of COVID-19 virus using reverse transcription and polymerase chain reaction. Specifically, the qualitative assay is a TaqMan assay using the primers and probes constructed based on the genome of the COVID-19 virus. The invention further relates to a diagnostic kit that comprises nucleic acid molecules for the detection of the COVID-19 virus.
FINRA since Oct 2011
Desktop Engineer
National Institute of Standards and Technology Jun 2005 - Oct 2011
IT Specialist
US Government, Department of Health & Human Services, HRSA Jun 2003 - Feb 2005
Technical Consultant
Education:
University of Pittsburgh 1998 - 2003
B.A., Economics, Computer Science, Information Science